Repligen
RGEN
#2575
Rank
$6.65 B
Marketcap
$118.18
Share price
0.31%
Change (1 day)
-7.12%
Change (1 year)
Categories

Earnings for Repligen (RGEN)

Earnings in 2025 (TTM): $83.89 Million USD

According to Repligen 's latest financial reports the company's current earnings are $0.73 Billion USD. , an increase over its 2024 earnings that were of -$6.31 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Repligen from 1996 to 2025

Annual earnings

Year Earnings Change
2025 $83.89 M-1430.84%
2024 -$6.31 Million-113.01%
2023 $48.45 M-78.01%
2022 $0.22 B33.37%
2021 $0.16 B131.52%
2020 $71.35 M101.31%
2019 $35.44 M25.93%
2018 $28.14 M105.61%
2017 $13.68 M-11.46%
2016 $15.46 M14.91%
2015 $13.45 M20.26%
2014 $11.18 M-51.49%
2013 $23.06 M90.98%
2012 $12.07 M
2010 $0.17 M-103.81%
2009 -$4.59 Million-223.84%
2008 $3.7 M
2006 -$2.49 Million229.64%
2005 -$0.76 Million-89.16%
2004 -$6.97 Million-16.86%
2003 -$8.38 Million88.72%
2002 -$4.44 Million-27.88%
2001 -$6.16 Million-1.74%
2000 -$6.27 Million85.93%
1999 -$3.37 Million159.16%
1998 -$1.3 Million85.71%
1997 -$0.7 Million-70.83%
1996 -$2.4 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
$10.19 B 12,048.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
$7.30 B 8,610.78%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
$10.84 B 12,824.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$9.32 B 11,018.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-$0.11 Billion-229.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
$0.37 B 346.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
$0.63 B 658.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
$0.12 B 47.18%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$0.48 B 475.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
-$99.51 Million-218.60%๐Ÿ‡บ๐Ÿ‡ธ USA